
News|Articles|August 15, 2013
INFOGRAPHIC: Oral oncolytics
The pros and cons of oral oncolytics and intravenous drugs.
Advertisement
The pros and cons of oral oncolytics and intravenous drugs.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
FDA issues draft guidance on MRD and complete response as primary endpoints for accelerated multiple myeloma drug approvals
3
TrumpRx launches; some experts question its long-term value
4
Cancer survival fell and deaths rose during first two years of COVID-19
5























